Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Ionis Pharmaceuticals Inc

IONS
32,98
-0,21 (-0,63%)
Ultimo aggiornamento: 17:07:47
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/2/202513:05BWIonis to present at upcoming investor conferences
24/2/202522:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202513:00BWNew positive donidalorsen data to be presented at AAAAI/WAO..
19/2/202522:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
19/2/202517:15EDGAR2Form 8-K - Current report
19/2/202513:00BWIonis reports fourth quarter and full year 2024 financial..
13/2/202522:53EDGAR2Form SCHEDULE 13G - Statement of Beneficial Ownership by..
07/2/202500:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202500:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202513:05BWIonis to hold fourth quarter and full year 2024 financial..
04/2/202522:56EDGAR2Form 144 - Report of proposed sale of securities
04/2/202522:45EDGAR2Form 144 - Report of proposed sale of securities
04/2/202501:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/2/202501:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202523:43EDGAR2Form 144 - Report of proposed sale of securities
31/1/202523:41EDGAR2Form 144 - Report of proposed sale of securities
31/1/202523:03EDGAR2Form 144 - Report of proposed sale of securities
31/1/202523:02EDGAR2Form 144 - Report of proposed sale of securities
31/1/202523:01EDGAR2Form 144 - Report of proposed sale of securities
31/1/202522:59EDGAR2Form 144 - Report of proposed sale of securities
31/1/202522:58EDGAR2Form 144 - Report of proposed sale of securities
23/1/202513:30GLOBEFDA and EMA Accept Applications for Higher Dose Regimen of..
18/1/202501:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202501:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202501:31EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:30EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:29EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:28EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:25EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:23EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:22EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:21EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:19EDGAR2Form 144 - Report of proposed sale of securities
17/1/202501:18EDGAR2Form 144 - Report of proposed sale of securities
13/1/202514:00PRNUSIonis enters new chapter in 2025 as commercial-stage biotech..
Apertura: 33,255 Min: 32,8667 Max: 33,54
Chiusura: 33,19

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network